Tormere Analytics

>/

Overview Market News Stock Research Charts Portfolio Lab Options Lab Calculators Watchlist

Privacy Policy Terms of Service

Bio-Rad Laboratories, Inc. (BIO): Insider Trading, Congress Trades & Research | Tormere

BIO

$380.99+2.30%download financials (.py)

BIO-RAD LABORATORIES, INC.

Market Cap

$10.2B

Live price × shares (2026-10-18)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

1.06

60mo monthly vs SPY

P/E (TTM)

46.4

TTM to Jun 2026 · diluted EPS

P/S (TTM)

3.9

Price / TTM revenue

P/B

1.4

Price / stockholders equity

EV/EBITDA

49.8

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Zura Bio shares jump on Wedbush buy call ahead of trial data

Investing.com · 2026-10-27

Piper Sandler reiterates Climb Bio stock rating after ASN data By Investing.com

Investing.com South Africa · 2026-10-27

BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?

Yahoo Finance · 2026-10-27

Cellectar Biosciences, Inc. (CLRB) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-27

Lycia leaps onto Nasdaq with upsized $318M IPO as Windward breezes toward listing

Fierce Biotech · 2026-10-26

Genmab takes off after Phase III success

Biostock · 2026-10-26

Pumitamig shows efficacy in second-line lung cancer

Biostock · 2026-10-26

Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-25

Exclusive: OpenAI has acquired Orchestra Bio

Axios · 2026-10-20

Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026

Yahoo Finance · 2026-10-14

Cell Isolation / Cell Separation - Global Strategic Business Report: Secure Share of a US$42.8 Billion Market by 2030 as BD Biosciences, Beckman Coulter, Bio-Rad and Thermo Fisher Accelerate

Yahoo Finance · 2026-10-14

Global Cell-Based Assays Market Report 2026-2030 | Secure Share in the $54.79 Billion Market Growing at 13.3% as Promega, Bio-Rad, PerkinElmer, and Danaher Scale AI Automation

Yahoo Finance · 2026-10-14

Global Protein Labeling Market Report 2026: Size, Share, Trends, and 2030 Forecast | Capture a $4.89 Billion Market as Thermo Fisher, Merck, Bio-Rad, and Abcam Scale Automation

Yahoo Finance · 2026-10-13

Global Bioconjugation Reagents Market Report 2026: Size, Trends, and Forecast to 2030 | Accelerate ADC and Click Chemistry Growth with Thermo Fisher, Merck, Danaher, and Bio-Rad

Yahoo Finance · 2026-10-13

Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption

Yahoo Finance · 2026-10-01

Informational purposes only, not investment advice.

BIO-RAD LABORATORIES, INC. (BIO)

tormere.com/research/BIO · generated 2026-10-28

$380.99

+2.30%

General Information

Price$380.99

Change+2.30%

Market Cap$10.2B

SectorHealth Care

IndustryLife Sciences Tools & Services

ExchangeNYSE

Beta (raw, 60mo vs SPY)1.06

Signals

Insider Velocity—

Congress Trades (90d)—

Short Volume

73% of daily vol

Conviction Score—

Price Chart (1 Year)

Recent News

Zura Bio shares jump on Wedbush buy call ahead of trial data — Investing.com · 2026-10-27
Piper Sandler reiterates Climb Bio stock rating after ASN data By Investing.com — Investing.com South Africa · 2026-10-27
BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount? — Yahoo Finance · 2026-10-27
Cellectar Biosciences, Inc. (CLRB) Stock Price, News, Quote & History — Yahoo! Finance Canada · 2026-10-27
Lycia leaps onto Nasdaq with upsized $318M IPO as Windward breezes toward listing — Fierce Biotech · 2026-10-26

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →